Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411318 · ClinicalTrials.gov registry record · NA
Influence of Lifestyle Factors on Neutrophil Migration Pilot Study
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02411318: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT02411318 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02411318, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This study will determine how common lifestyle practices affect the behavior of neutrophils (a type of immune cell) at shorter time scales than previously possible.
Primary Outcome
Participants will ride a stationary bike and maintain their target heart rate for 30 min. Blood samples via lancet will be collected at baseline, 30 min (immediately post intervention), and 60 min.
Interventions
- BEHAVIORAL Exercise
- DRUG ProLab 200mg caffeine capsule
- OTHER Ethanol ingestion
- DRUG Glucose Tolerance Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2014-09-25 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT02411318 record still lists
NCT02411318 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Exercise is the first listed.
NCT02411318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02411318 about?
NCT02411318 is a clinical study titled "Influence of Lifestyle Factors on Neutrophil Migration Pilot Study". This study will determine how common lifestyle practices affect the behavior of neutrophils (a type of immune cell) at shorter time scales than previously possible.
What is the current status of trial NCT02411318?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2014-09-25. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02411318?
The interventions under investigation include: Exercise (BEHAVIORAL), ProLab 200mg caffeine capsule (DRUG), Ethanol ingestion (OTHER), Glucose Tolerance Drink (DRUG).
Who is sponsoring clinical trial NCT02411318?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02411318's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI